Inhibition of phase III activity by acid in canine stomach.
Very few phase III activity of the interdigestive migrating contractions (phase III) occurs in the stomach of fasted duodenal ulcer patients. But the mechanism is not well understood. In this study, we studied the effect of gastric and duodenal acidification on the spontaneous phase III activity in the upper gastrointestinal tract of conscious dogs. Gastric and duodenal motor activity in 5 conscious dogs was monitored by means of chronically implanted force transducers. Intragastric pH changes were measured by placing a pH glass electrode in the gastric antrum. Intragastric and intraduodenal acidification was achieved by i.v. infusion of histamine, and by intragastric and intraduodenal instillation of acidic solutions of different pHs. The plasma motilin concentrations were measured by radioimmunoassay. Histamine (40 micrograms/kg/h) inhibited spontaneous phase III activity, but the histamine-induced inhibition was completely prevented by pretreatment with famotidine, a potent histamine H2 receptor antagonist (0.3 mg/kg, i.v.). Intragastric acidification at pH 1.0 strongly inhibited spontaneous phase III activity, but an acidic solution at pH 2.0 had no effect in inhibiting phase III activity. Intraduodenal acidification at pH 1.0 also inhibited spontaneous phase III activity. Histamine injection and gastric and duodenal acidification at pH 1.0 strongly suppressed motilin release. It is concluded that gastric and duodenal acidification at pH 1.0 inhibits the occurrence of the spontaneous phase III activity, and the suppression of endogenous release of motilin due to gastric and duodenal acidification at pH 1.0 is involved in this inhibitory mechanism.
Matsunaga
Y
Y
Gastrointestinal Research Laboratories, Gunma University, Maebashi, Japan.
Yamamoto
O
O
Ueki
S
S
Haga
N
N
Mizusawa
F
F
Mizumoto
A
A
Sano
I
I
Itoh
Z
Z
D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D004381:Duodenal Ulcer / Q000139:chemically induced; D004566:Electrodes; D004594:Electrophysiology; D015738:Famotidine / Q000494:pharmacology; D005260:Female; D005744:Gastric Acid / Q000378:metabolism*; D005769:Gastrointestinal Motility / Q000187:drug effects / Q000502:physiology*; D006632:Histamine / Q000008:administration & dosage / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008297:Male; D009037:Motilin / Q000097:blood; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D013276:Stomach Ulcer / Q000139:chemically induced
D009037:Motilin; D015738:Famotidine; D006632:Histamine